External validation of predictive scores for diabetes remission after metabolic surgery.

ABSTRACT:

Purpose

Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic surgery have been established to facilitate the decision-making process. The purpose of the study is to validate the performance of available risk prediction scores for diabetes remission a year after surgical treatment and to determine the optimal model.

Methods

A retrospective analysis comprised 252 patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2009 and 2017 and completed 1-year follow-up. The literature review revealed 5 models, which wer

SUBMITTER: Karpinska IA 

PROVIDER: S-EPMC8847237 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature